Previous Page  19 / 31 Next Page
Information
Show Menu
Previous Page 19 / 31 Next Page
Page Background

Neumol Pediatr 2016; 11 (1) Sup: S5-S19

C o n t e n i d o d i s p o n i b l e e n h t t p : / / www. n e umo l o g i a - p e d i a t r i c a . cl

S17

Consenso chileno SER-SOCHINEP para el manejo del asma severo en el niño

uso reduce la inflamación de la vía aérea y mejora la función

pulmonar

69

.

Dupilumab

Anticuerpo monoclonal recombinante completamente

humano, que actúa bloqueando la subunidad alfa del receptor

de IL-4, con lo que se inhibe la acción de IL-4 e IL-13. Se

administra por vía subcutánea. Su uso en adultos ha demostrado

una reducción significativa del número de exacerbaciones

acompañado de una mejoría de la función pulmonar y del grado

de control del asma

70,71

.

La Dra Ana María Herrera obtuvo un Grant de Laboratorio

Novartis para proyecto de investigación el año 2015. Los

demás autores no presentan conflicto de intereses

REFERENCIAS

1. Fischer GB, Camargos PA, Mocelin HT. The burden of asthma

in children: a Latin American perspective. Paediatr Respir Rev

2005; 6: 8-13.

2. Godard P, Chanez P, Siraudin L, Nicoloyannis N, Duru G. Costs

of asthma are correlated with severity: a 1-year prospective

study. Eur Respir J 2002; 19: 61–7.

3. Guilbert T W, Bacharier LB, Fitzpatrick AM. Severe asthma in

children. J Allergy Clin Immunol Pract 2014; 2: 489-500.

4. Bousquet J, Mantzouranis E, Cruz AA, Ait-Khaled N, Baenna-

Cagnani CE, Bleecker ER, et al. Uniform definition of asthma

severity, control, and exacerbations: document presented for

the World Health Organization Consultation on Severe Asthma. J

Allergy Clin Immunol 2010; 126: 926–38.

5. GINA: Update 2016 Disponible en:

www.ginasthma.com

6. Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ,

et al. International ERS/ATS guidelines on definition, evaluation

and treatment of severe asthma. Eur Respir J 2014; 43: 343–73.

7. Bush A, Zar HJ. WHO universal definition of severe asthma.

Curr Opin Allergy Clin Immunol 2011; 11: 115–21.

8. American Thoracic Society .Proceedings of the ATS workshop

on refractory asthma: current understanding, recommendations,

and unanswered questions.. Am J Respir Crit Care Med 2000;

162: 2341–51.

9. Bel EH, Sousa A, Fleming L, Bush A, Chung KF, Versnel J,

et al. Diagnosis and definition of severe refractory asthma: an

international consensus statement from the Innovative Medicine

Initiative (IMI). Thorax 2011; 66: 910–17.

10. Hedlin G, Bush A, Lodrup Carlsen K, Wennergren G, de

Benedictis FM, Melen E, et al. Problematic severe asthma in

children, not one problem but many: a GA2LEN initiative. Eur

Respir J 2010; 36: 196–201.

11. Bush A, Saglani S. Management of severe asthma in children.

Lancet 2010; 376: 814-25.

12. Bracken M, Fleming L, Hall P, Van Stiphout N, Bossley C,

Biggart E , et al. The importance of nurse-led home visits in the

assessments of children with problematic asthma. Arch Dis Child

2009; 94: 780–4.

13. Konradsen JR, Nordlund B, Lidegran M, Pedroletti C, Gronlund

H, van Hage M, et al. Problematic severe asthma: a proposed

approach to identifying children who are severely resistant to

therapy. Pediatr Allergy Immunol 2011; 22: 9–18.

14. Sharples J, Gupta A, Fleming L, Bossley CJ, Bracken –King

M, Hall P, et al. Long term

effectiveness of a staged assessment for paediatric problematic

severe asthma. Eur

Respir J 2012; 40: 264–7.

15. Bozzetto S, Carraro S, Zanconato S, Baraldi E. Severe asthma

in childhood: diagnostic and management challenge. Curr Opin

Pulm Med 2015, 21:16–21.

16. Fokkens W, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F,

et al. EPOS 2012: European position paper on rhinosinusitis

and nasal polyps. Rhinology 2012; 50: 1– 12.

17. Pijnenburg MW, Baraldi E, Brand PL, Carlsen KH, Eber E,

Frischer T, et al. Monitoring Asthma in Children. Eur Respir J

2015; 45: 906-25.

18. Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S,

Canonica GW, Casale TB, et al. Allergic Rhinitis and its impact in

Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Inmunol

2010; 126: 466-76.

19. Tolia V, Vandenplas Y. Systematic review: the extra-

oesophageal symptoms of gastro-oesophageal reflux disease in

children. Aliment Pharmacol Ther 2009; 29: 258–72.

20. Chan WW, Chiou E, Obstein Kl, tignor AS, Whitlock TL. The

efficacy of proton pump inhibitors for the treatment of asthma in

adults: a meta – analysis. Arch Intern Med 2011; 171: 620-9.

21. Holguin F, Bleecker ER, Busse WW, Calhoun WJ, Castro

M, Erzurum SC, et al. Obesity and asthma: an association

modified by age of asthma onset. J Allergy Clin Immunol. 2011

Jun;127:1486-93.

22. Scott HA, Gibson PG, Garg ML, Pretto JJ, Morgan PJ,

Callister R, et al. Dietary restriction and exercise improve airway